Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Janna MorawitzNils-Martin BruckmannFrederic DietzelTim UllrichAnn-Kathrin BittnerOliver HoffmannEugen RuckhäberleSvjetlana MohrmannLena HäberleMarc IngenwerthDaniel Benjamin AbrarLino Morris SawickiKatharina BreuckmannWolfgang Peter FendlerKen HerrmannChristian BuchbenderGerald AntochLale UmutluJulian KirchnerPublished in: European journal of nuclear medicine and molecular imaging (2021)
[18F]-FDG PET/MRI outperforms CT or MRI in detecting nodal involvement on a patient-based analysis and on a lesion-based analysis. Furthermore, PET/MRI was superior to CT or MRI in detecting lymph node metastases in all lymph node stations. Of all the tested imaging modalities, PET/MRI showed the highest sensitivity, whereas CT showed the lowest sensitivity, but was most specific.